High-risk human papillomavirus in mammary gland carcinomas and non-neoplastic tissues of Mexican women: No evidence supporting a cause and effect relationship

Breast

Volumn 20, Issue 2, 2011, Pages 184-189

  Herrera Goepfert, Roberto ^a   Khan, Noureen A ^b   Koriyama, Chihaya ^b   Akiba, Suminori ^b   Pérez Sánchez, Víctor Manuel ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Breast cancer; High risk human papillomavirus; Integrins; Neoadjuvant therapy; Viral load

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; HISPANIC; HISTOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; TUMOR VOLUME; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS LOAD;

EID: 79952617083     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2010.11.006     Document Type: Article

References (33)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Bosetti C., Malvezzi M., Chatenoud L., Negri E., Levi F., La Vecchia C. Trends in cancer mortality in the Americas, 1970-2000. Ann Oncol 2005, 16:489-511.
3. Malvezzi M., Bosetti C., Chatenoud L., Rodríguez T., Levi F., Negri E., et al. Trends in cancer mortality in Mexico, 1970-1999. Ann Oncol 2004, 15:1712-1718.
4. Rizo-Ríos P., Sierra-Colindres M.I., Vázquez-Piñón G., Cano-Guadiana M., Meneses-García A., Mohar A. Registro hospitalario de cáncer: compendio de cáncer 2000-2004. Cancerologia 2007, 2:203-287.
5. McPherson K., Steel C.M., Dixon J.M. Breast cancer-epidemiology, risk factors, and genetics. BMJ 2000, 321:624-628.
6. Lawson J.S., Günsburg W.H., Whitaker N.J. Viruses and human breast cancer. Future Microbiol 2006, 1:33-51.
7. Hachana M., Trimeche M., Ziadi S., Amara K., Korb S. Evidence for a role of the Simian virus 40 in human breast carcinomas. Breast Cancer Res Treat 2009, 113:43-58.
8. Di Lonardo A., Venuti A., Marcante M.L. Human papillomavirus in breast cancer. Breast Cancer Res Treat 1992, 21:95-100.
9. Hennig E.M., Suo Z., Thoresen S., Holm R., Kvinnsland S., Nesland J.M. Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat 1999, 53:121-135.
10. de Cremoux P., Thioux M., Lebigot I., Sigal-Zafrani B., Salmon R., Sastre-Garau X. No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat 2008, 109:55-58.
11. Lindel K., Forster A., Altermatt H.J., Greiner R., Gruber G. Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women. Breast 2007, 16:172-177.
12. Damin A.P., Damin D.C., Alexandre C.O.P. HPV infection and breast cancer (letter to the editor). Breast 2007, 16:222.
13. Yasmeen A., Ricciardi R., Kassab A., Bismar T.A., Al Moustafa A.-E. High-risk HPVs in human breast cancer and normal mammary tissues (letter to the editor). Breast 2007, 16:445.
14. Tumors of the breast. Pathology & genetics, tumors of the breast and female genital organs. WHO classification of tumors 2003, 9-80. IARC Press, Lyon, France. F.A. Tavassoli, P. Devilee (Eds.).
15. Kleter B., van Doorn L.J., Schrauwen L., Molijn A., Sastrowijoto S., ter Schegget J., et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999, 37:2508-2511.
16. Yu Y., Morimoto T., Sasa M., Okazaki K., Harada Y., Fujiwara T., et al. HPV 33 DNA in premalignant and malignant breast lesions in Chinese and Japanese populations. Anticancer Res 1999, 19:5057-5061.
17. Peitsaro P., Johansson B., Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002, 40:886-891.
18. Thike A.A., Chng M.J., Fook-Chong S., Tan P.H. Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of h-score with pathological parameters. Pathology 2001, 33:21-25.
19. Cantú-de León D., Pérez-Montiel D., Nemcova J., Mykyskova I., Turcios E., Villavicencio V., et al. Human papillomavirus (HPV) in breast tumors: prevalence in a group of Mexican patients. BMC Cancer 2009, 9:26-31.
20. Damin A.P.S., Karam R., Zettler C.G., Caleffi M., Alexandre C.O.P. Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat 2004, 84:131-137.
21. Tsai J.H., Tsai C.H., Cheng M.H., Lin S.J., Xu F.L., Yang C.C. Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol 2005, 75:276-281.
22. Gumus M., Yumuk P.F., Salepci T., Aliustaoglu M., Dane F., Ekenel M., et al. HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples. J Exp Clin Cancer Res 2006, 25:515-521.
23. Khan N.A., Castillo A., Koriyama C., Kijima Y., Umekita Y., Ohi Y., et al. Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer 2008, 99:408-414.
24. Guo M., Sneige N., Silva E.G., Jan Y.J., Cogdell D.E., Lin E., et al. Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. Mod Pathol 2007, 20:256-266.
25. de Villiers E.M., Sandstrom R.E., zur Hausen H., Buck C.E. Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res 2005, 7:R1-R11. 10.1186/bcr940.
26. Widschwendter A., Brunhuber T., Wiedemair A., Mueller-Holzner E., Marth C. Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol 2004, 31:292-297.
27. Yoon C.S., Kim K.D., Park S.N., Cheong S.W. α6 Integrin is the main receptor of human papillomavirus Type 16 VLP. Biochem Biophys Res Commun 2001, 283:668-673.
28. Taddei I., Faraldo M.M., Teulière J., Deugnier M.A., Thiery J.P., Glukhova M.A. Integrins in mammary gland development and differentiation of mammary epithelium. J Mammary Gland Biol Neoplasia 2003, 8:383-394.
29. Mendizabal-Ruiz A.P., Morales J.A., Ramírez-Jirano L.J., Padilla-Rosas M., Morán- Moguel M.C., Montoya-Fuentes H. Low frequency of human papillomavirus DNA in breast cancer tissue. Breast Cancer Res Treat 2009, 114:189-194.
30. Flores Y.N., Bishai D.M., Shah K.V., Lazcano-Ponce E., Lörincz A., Hernández M., et al. Risk factors for cervical cancer among HPV positive women in Mexico. Salud Publica Mex 2008, 50:49-58.
31. Singh R.K., Maulik S., Mitra S., Mondal R.K., Basu P.S., Roychowdhury S., et al. Human papillomavirus prevalence in postradiotherapy uterine cervical carcinoma patients: correlation with recurrence of the disease. Int J Gynecol Cancer 2006, 16:1048-1054.
32. Badaracco G., Savarese A., Micheli A., Rizzo C., Paolini F., Carosi M., et al. Persistence of HPV after radio-chemotherapy in locally advanced cervical cancer. Oncol Rep 2010, 23:1093-1099.
33. Saxena A., Yashar C., Taylor D.D., Gercel-Taylor C. Cellular response to chemotherapy and radiation in cervical cancer. Am J Obstet Gynecol 2005, 192:1399-1403.